The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
NCT01277237
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Non Alcoholic Fatty Liver Disease
Interventions
DRUG:
Omacor
DRUG:
lactose tablet
Sponsor
University of Edinburgh
Collaborators
[object Object]